JJ
Johnson & Johnson Portfolio holdings
AUM
$334M
This Quarter Return
+1.66%
1 Year Return
+16.18%
3 Year Return
+88.55%
5 Year Return
–
10 Year Return
–
AUM
$342M
AUM Growth
+$342M
(-11%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
97.19%
Holding
20
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.99% |
| 2 | Technology | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Protagonist Therapeutics
PTGX
$3.67B
| $118M | 34.65% | 2,449,183 | – | – |
|
2
CVRx
CVRX
$205M
| $50.2M | 14.68% | 4,103,430 | – | – |
|
3
MeiraGTx Holdings
MGTX
$587M
| $45M | 13.17% | 6,641,064 | – | – |
|
4
Legend Biotech
LEGN
$6.41B
| $27.6M | 8.08% | 814,586 | – | – |
|
|
RAPP
5
Rapport Therapeutics
RAPP
$643M
| $25.1M | 7.33% | 2,498,051 | – | – |
|
6
Procept Biorobotics
PRCT
$2.23B
| $20.9M | 6.1% | 357,939 | – | – |
|
|
NBTX
7
Nanobiotix
NBTX
$429M
| $20.1M | 5.89% | 5,623,816 | – | – |
|
|
CTNM
8
Contineum Therapeutics
CTNM
$293M
| $13.8M | 4.04% | 1,979,173 | – | – |
|
9
Xencor
XNCR
$580M
| $7.96M | 2.33% | 748,062 | – | – |
|
10
Arrowhead Research
ARWR
$3.05B
| $3.15M | 0.92% | 247,598 | – | – |
|
11
Fate Therapeutics
FATE
$120M
| $2.67M | 0.78% | 3,379,064 | – | – |
|
12
Rallybio
RLYB
$22.4M
| $2.38M | 0.7% | 3,636,363 | – | – |
|
13
Neumora Therapeutics
NMRA
$280M
| $1.85M | 0.54% | 1,849,445 | – | – |
|
14
Nano X Imaging
NNOX
$247M
| $793K | 0.23% | 158,852 | – | – |
|
15
Vor Biopharma
VOR
$250M
| $771K | 0.23% | 1,074,658 | – | – |
|
16
Lyell Immunopharma
LYEL
$213M
| $443K | 0.13% | 823,317 | – | – |
|
17
Standard BioTools
LAB
$481M
| $337K | 0.1% | 311,967 | – | – |
|
18
Adicet Bio
ACET
$59.9M
| $275K | 0.08% | 364,472 | – | – |
|
19
BiomX
PHGE
$14.3M
| $53.8K | 0.02% | 96,866 | – | – |
|
20
Senseonics Holdings
SENS
$374M
| $35.8K | 0.01% | 54,621 | – | – |
|